Benefits of convalescent plasma for COVID-19 are still unclear

(American Chemical Society) With vaccines and therapeutic drugs for COVID-19 still under development, doctors are wondering whether antibody-rich plasma infusions from the blood of recovered patients could be a more immediate way to keep hospitalized patients alive and off ventilators. However, an article inChemical& Engineering News, the weekly newsmagazine of the American Chemical Society, indicates that, despite some anecdotal evidence, scientists still don't have high-quality data showing that the treatment actually works.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news